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Abstract
The cellular response to DNA double strand breaks (DSBs) involves the ordered assembly of repair proteins at or near sites of
damage. This process is mediated through post-translational protein modifications that include both phosphorylation and
ubiquitylation. Recent data have demonstrated that recruitment of the repair proteins BRCA1, 53BP1, and RAD18 to ionizing
irradiation (IR) induced DSBs is dependent on formation of non-canonical K63-linked polyubiquitin chains by the RNF8 and
RNF168 ubiquitin ligases. Here we report a novel role for K63-ubiquitylation in response to replication-associated DSBs that
contributes to both cell survival and maintenance of genome stability. Suppression of K63-ubiquitylation markedly increases
large-scale mutations and chromosomal aberrations in response to endogenous or exogenous replication-associated DSBs.
These effects are associated with an S-phase specific defect in DNA repair as revealed by an increase in residual 53BP1 foci.
Use of both knockdown and knockout cell lines indicates that unlike the case for IR-induced DSBs, the requirement for K63-
ubiquitylation for the repair of replication associated DSBs was found to be RNF8-independent. Our findings reveal the
existence of a novel K63-ubiquitylation dependent repair pathway that contributes to the maintenance of genome integrity
in response to replication-associated DSBs.
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Introduction
To maintain genomic stability mammalian cells have evolved
extensive signalling and repair networks that respond to DNA
damage. DNA double strand breaks (DSBs) are considered the
most cytotoxic lesions and their inaccurate repair can lead to
mutation, chromosomal translocation and tumorigenesis [1,2].
DSBs are caused by both exogenous agents and endogenous
processes, including ionizing radiation (IR) and collapsed replica-
tion forks, respectively. Cells respond to DSBs through sequential
recruitment of various signalling and repair proteins, many of
which can be visualized as discrete foci at sites of damage [3,4].
Although many protein-protein interactions in repair signalling
depend on phosphorylation and phospho-binding domains, an
important role has also emerged for protein ubiquitylation. In the
case of IR-induced direct two-ended DSBs, the ubiquitin (Ub)
ligases RNF8 and RNF168 are required for the recruitment of
essential downstream repair proteins including BRCA1, 53BP1,
and RAD18 [5,6,7,8,9,10,11,12]. RNF8 binds to phosphorylated
MDC1 at DSBs through its FHA domain and together with
UBC13, ubiquitylates histones H2A and H2AX. RNF8-UBC13
catalyses the formation of a polyUb chain, in which successive Ub
molecules are linked through lysine 63 (K63-ubiquitylation).
Unlike K48-ubiquitylation, which promotes protein degradation,
K63-ubiquitylation promotes protein interactions [13,14]. K63-
ubiquitylation of H2A and H2AX facilitate recruitment of
RNF168 through its MIU (motif interacting with ubiquitin)
domains [10,11]. RNF168 is encoded by the gene mutated in
RIDDLE syndrome and functions to further amplify K63-
ubiquitylation of histones and possibly other substrates [10,11].
RNF8 and RNF168 dependent K63-ubiquitylation mediates
recruitment of the RAP80-ABRA1-BRCA1 complex and the
accumulation of 53BP1 to DNA lesions [5,6,7,8,10,11]. RNF8
dependent K63-ubiquitylation also promotes binding of RAD18,
which in turn mediates recruitment of the homologous recombi-
nation (HR) factor RAD51C [12]. Defects in RNF8 or RNF168
impair K63-ubiquitylation and recruitment of these essential DNA
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repair factors resulting in increased sensitivity to IR-induced
DSBs.
In this study we investigated the importance of K63-ubiquityla-
tion in DSB-repair during S-phase. Recently, it has become clear
that, besides IR-induced two-ended DSBs produced in G2-phase,
secondary replication-associated DSBs in S-phase are a major
substrate for HR-dependent repair following IR [15]. These
secondary DSBs are the result of damage encountered by ongoing
replication forks thereby leading to their collapse. This type of
DSB also occurs when endogenously produced single strand
breaks (SSBs) arrive at replication forks, resulting in fork run-off
[16]. Their repair is also critical for maintenance of genome
stability and for the response to several S-phase specific
chemotherapeutic agents. This includes the topoisomerase I
poison camptothecin (CPT), which exerts its cytotoxic effect by
stabilizing a SSB intermediate and greatly increasing the number
of collapsed forks during replication [17,18,19], as well as
inhibitors of poly ADP-ribose polymerase (PARP), which similarly
increase SSBs that collide with replication forks [20,21,22]. Here,
we report that K63-ubiquitylation plays a crucial and unique role
in the repair of such replication-associated DNA DSBs. Partial
disruption of K63-ubiquitylation was achieved through stable
transgene expression of a Ub allele harbouring a K63R mutation.
The resulting ‘hypomorphic’ allele revealed a unique phenotype
demonstrating the remarkable dependence on K63-ubiquitylation
for accurate repair of DNA double strand breaks that occur in S-
phase of the cell cycle. Disruption of K63-ubiquitylation resulted
in a dramatic increase in genetic instability and an increased
sensitivity to replication-associated DSBs. The DNA repair defect
observed after suppression of K63-ubiquitylation is characterized
by an increase in S-phase specific damage and residual 53BP1 foci.
Furthermore, we provide strong genetic evidence using RNF8
knockout cells that in contrast to IR-induced DSBs, K63-
ubiquitylation required to confer resistance to damage during S-
phase is largely RNF8 independent.
Materials and Methods
Cell culture and transfection
Construction of WTUb-GFP and K63RUb-GFP expression
plasmids has been described previously [23]. For this study we
regenerated previously described cell-lines [24]. A549 (human
epithelial lung carcinoma cells) from ATCC were used or cells
were cotransfected with WTUb or K63RUb plasmids and a
pBabePuro plasmid using FuGene 6 (Roche, Basel, Zwitserland)
and stable expressing cells were selected in 1 mg/ml puromycin
(Sigma). High expressing cells were sorted for by flow cytometry
based on GFP expression (FACSAria, BD Biosciences Pharmin-
gen, San Diego, California, USA). Cells were cultured in DMEM
(Invitrogen) supplemented with 10% FBS (PAA), 1 mM Sodium-
Pyruvate (Gibco) at 37uC and 5% CO2. Primary WT MEFs and
same litter RNF8-/- MEFs were generously provided by R.
Hakem [25]. MEFs were immortalized by 3T3 passaging and
cultured similar as described above, medium was additionally
supplemented with 100 nM b-mercaptoethanol.
Plasmids and lentiviral work
WT-Ub-GFP and K63R-Ub-GFP inserts were PCR amplified
from the original vectors and cloned as Age1/EcoR1 fragments
into lentiviral vector pJLM1. The following lentiviral shRNA
constructs were used for knockdown: TRCN0000007216
(UBC13), TRCN0000015555 (SHPRH), TRCN0000272562
(HLTF), TRCN0000003438 (RNF8). Lentiviral particles were
generated by co-transfection of 293T cells with packaging plasmids
pCMVdR8.74psPAX2 and pMD2.G together with shRNA vector
pLKO.1 or pLJM1. Virus supernatant was harvested 48 and
72 hrs post transfection. A549 cells or MEFs were transduced
overnight with lentiviral supernatant in the presence of 8 mg/ml
polybrene. Infected cells were grown in 2 mg/ml puromycin
containing media for 2 days to select for stable expressing pools.
siRNA
The following short interfering RNA (siRNA) duplexes were
purchased from Sigma targeting the indicated gene products:
RNF8-si; 59-GGA CAA UUA UGG ACA ACA AdTdT-39,
RAP80-si; 59- UUG UGA AGC AGG UAC AGA GUU UCC
CdTdT-39. Stealth RNAi Negative Control Med GC was ordered
from Invitrogen (12935-300). For siRNA experiments, cells were
double transfected at 90% confluency, 72 and 24 hrs before start
of the experiment, with the indicated siRNA’s at a final
concentration of 100 nM using oligofectamine (Invitrogen).
RNA extraction and quantitative RT-PCR
RNA was isolated using Tri reagent (Sigma) according to
manufacturers’ instructions. RNA samples were reverse tran-
scribed using q-Script kit as described by manufacturer (Quantas).
Real-time PCR was performed on an Eppendorf Realplex2
mastercycler using SYBR green (Quantas). The following Q-
PCR primers were used: RNF8 F_59-TGC TAG AGA ATG AGC
TCC AAT G-39; RNF8 R_59-CGC ACT ACC TGG CAG TCT
TT-39; RAP80 F_59-AGG TAT CCT GCC CGC TAT GT-39;
RAP80 R_59-TCA CTC TTG GTC TTG GCC TC-39; UBC13
F_59-AGC CCA GAC ATC TTC AGT CC-39; UBC13 R_59-
TAA ACC AGG ATG GGG GAA AT-39.
Clonogenic survival assays
Cells were seeded (range 200 to 5000 cells) in triplicate in 60-
mm dishes either directly in DMEM or DMEM containing the
indicated concentrations of PARP-inhibitor KU0058948. For
CPT-assays cells were seeded to attach overnight before 24 hrs
CPT treatment. For IR-assays, 80% confluent cells were irradiated
with the indicated doses using a Cesium 137 source (GC-40E
Nordion, dose-rate 0.83 Gy/min), 1 hr after IR cells were seeded
similar to described above. Cells were incubated for 14 days to
obtain colony formation. Resulting colonies were fixed and stained
using 2% bromophenol blue in 80% ethanol, colonies containing
$ 50 cells were counted. All experiments were normalized for
plating efficiency. DNA-PK inhibitor KU0057788 treatment was
always started 1 h before additional treatments as indicated.
Proliferation assays
Cells were plated at a low density (10% confluence) in 6-well
plates at least in duplicate and left to attach overnight. Cells were
incubated at 37uC, 5% CO2 and growth was monitored using an
automated microscope (IncuCyte, Essen Instruments, Inc.,
Michigan, USA).
Mutation frequency assays
HPRT mutant- free cells were selected for by culturing cells in
DMEM supplemented with hypoxanthine, aminopterin and
thymidine (HAT) for 1 week. Cells were seeded (1x106) in 100-
mm dishes and cultured for 7 or 14 days in regular DMEM
(spontaneous mutations) or continuous treatments were started the
following day by adding DMEM containing PARP-inhibitor
KU0058948 (0, 1 mM) or CPT (0, 5 and 20 nM) or cells were
irradiated (0, 1, and 4 Gy) and cultured for 6 additional days.
Subsequently, cells (4x105) were seeded on 100-mm dishes in
K63-Ubiquitylation Maintains Genomic Integrity
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DMEM containing 30 mM 6-thioguanine (6-TG) and incubated
for 14 days to obtain colony formation. In parallel, cells were
plated (200) in regular DMEM to assess plating efficiency.
Colonies were fixed and stained using 2% bromophenol blue in
80% ethanol, colonies containing $ 50 cells were counted. DNA-
PK inhibitor KU0057788 treatment was started 1 h before
additional treatments as indicated.
Mutation spectra analyses
IR-induced mutated HPRT clones were obtained by seeding
1x105 HAT-selected cells in 35-mm dishes, individual dishes were
irradiated (6 Gy) 24 hrs later. After subculturing the cells for 6
days, from each 35-mm dish 1x105 cells were re-seeded in 35-mm
dishes in medium containing 30 mM 6-TG. CPT-induced mutants
were obtained in a similar way as described for IR-induced
mutants except cells were treated with 20 nM CPT for 6 days. For
spontaneous mutants 4x105 cells were seeded per 100-mm dish in
6-TG medium. One colony per dish was picked to avoid sister
clones and grown until enough cells were obtained to isolate total
RNA (TRI-reagent, Sigma) and genomic DNA (genomic DNA
isolation kit, Norgen) according to the manufacturer’s protocols.
The HPRT gene was subjected to RT-PCR, followed by
sequencing using the following overlapping primers: HPRT1
F_59-CTT CCT CCT CCT GAG CAG TC-39; HPRT2 R_59-
AAG CAG ATG GCC ACA GAA CT-39; HPRT3 F_59-CCT
GGC GTC GTG ATT AGT G-39; HPRT4 R_59-TTT ACT
GGC GAT GTC AAT AGG A-39; HPRT5 F_59-GAC CAG
TCA ACA GGG GAC AT-39; and HPRT6 R_59-ATG TCC
CCT GTT GAC TGG TC-39 [24]. In case there was no cDNA
product obtained, individual HPRT exons1-9 were PCR amplified
at the genomic DNA level, using the following primers:
Exon 1 F_59- GCT CCG CCA CCG GCT TCC TCC-39,
Exon 1 R_59-GCC GAA CCC GGG AAA CTG G-39, Exon 2
F_59-TGT AAT GCT CTC ATT GAA ACA GC-39, Exon 2
R_59-AAG GCC CTC CTC TTT TAT TTT T-39, Exon 3 F_59-
TTC CCA CCT CAC CTC TCA AG-39, Exon 3 R_59-TGG
TTT GCA GAG ATT CAA AGA A-59, Exon 4 F_59-TCA GTA
ATG GCC GAT TAG GAC-39, Exon 4 R_59-AGT CCC ACA
GAG GCA GAC AG-39, Exon 5 F_59-GAA ATA CCG TTT
TAT TCA TTG TAC TG-39, Exon 5 R_59-TGT GAA CTT
ACT TCC ACA ATC AAG A-39, Exon 6 F_59-GAA GGA CAA
CAT CAT AAC TCC CTA A-39, Exon 6 R_59-CTG CCA TGC
TAT TCA GGA CA-39, Exon 7 F_59-AAC AGC TTG CTG
GTG AAA AG-39, Exon 7 R_59-TCT GGC TTA TAT CCA
ACA CTT CG-59, Exon 8 F_59-TTT TTG TCA ATC ATT
TAA CCA TCT TT-59, Exon 8 R_59-CAT ATC AAA GTG
GGA GGC CAG T-39, Exon 9 F_59-GCT ACA GTG AGC CAA
CAT CAC G-39, Exon 9 R_59-CTG CTG ACA AAG ATT CAC
TGG-39.
Antibodies and western blot analysis
We employed the following antibodies: rabbit anti-UbK63
chains (Millipore), mouse anti-ubiquitin (Chemicon), mouse anti-
cH2AX (clone JBW301, Upstate), rabbit anti-cH2AX (Epitomics),
rabbit anti-53BP1 (Alexis). Following the indicated treatments
whole cell lysates were prepared using lysis buffer containing:
50 mM Tris-HCl [pH 7.4], 150 mM NaCl, 1% NP-40, 0.5%
Sodium Deoxycholate, 1 mM EDTA, 0.1% SDS, supplemented
with protease- (EDTA-free Complete tablets, Roche) and phos-
phatase inhibitors (PhosSTOP tablets, Roche). Supernatants were
boiled in Laemmli buffer and proteins were resolved by SDS-
PAGE. Proteins were transferred onto PVDF membranes and
blocked for 1 hour in 5% skim milk in TBS, 0.05% Tween-20
(TBS-T). Membranes were probed overnight at 4uC with
antibodies directed against K63 chains (1:1000) or ubiquitin
(1:500). Bound antibodies were visualized using HRP-linked
secondary antibodies (anti-rabbit (GE Healthcare) and anti-mouse
(GE Healthcare)) and ECL luminescence (Pierce).
Immunofluorescence microscopy
To visualize foci cells were grown on coverslips and treated as
indicated. Cells were fixed with 2% para-formaldehyde, 0.2%
Triton X-100 in PBS, pH 8.2 for 20 min. at room temperature.
Subsequently washed with PBS and treated with 0.5% NP-40 for
20 min. at room temperature. Cells were washed with PBS before
blocking with 2% BSA, 1% donkey serum in PBS for 1 hr at room
temperature. Samples were incubated with primary antibodies
anti-cH2AX (1:800), anti-53BP1 (1:1000). Antibodies were diluted
in 3% BSA in PBS and incubated overnight at 4uC. Cells were
washed with 0.5% BSA, 0.175% Tween20 in PBS and then
stained with Alexa Fluor 568 donkey anti-mouse/rabbit IgG,
Alexa Fluor 647 donkey anti-mouse/rabbit IgG (Molecular
Probes) for 45 min. at room temperature. Secondary antibodies
were diluted 1:500 in 3% BSA in PBS. DNA was counterstained
with DAPI (0.1 mg/ml) and mounted with Vectashield (Vector
Laboratories). S-phase cells were labelled using EdU-labeling kit
Alexa Fluor 647 (Click-iT EdU assays, Molecular Probes,
Invitrogen) according to manufacturer’s protocol. Confocal or
widefield three-dimensional images were visualized using Olympus
IX81 inverted microscope fitted with a Disk Scanning Unit (DSU),
equipped with PLAPON 60X 1.42NA or UPLSAPO 100X 1.4NA
oil-immersion objectives and a 16-bit Photometrics Cascade 512B
EM-CCD camera (Roper Scientific, Tuscon, AZ). Z-stacks, 55
planes, 0.29 micron were acquired using In Vivo Software (Media
Cybernetics, Bethesda, MA) or MetaMorph software and in some
cases computationally deconvolved using 25 iterations of 3D Blind
deconvolution (Autoquant, Media Cybernetics). Total intensity or
deconvolved images were analysed using Image Pro Analyzer
(Media Cybernetics).
Statistical Analysis
Unpaired Student’s t test was used to test significance between
populations, p,0.05 was considered significant (indicated by * in
the figures). Points and error bars plotted in the graphs of all
figures represent the mean 6 standard deviation (sd.) or standard
error of the mean (s.e.m.) as indicated.
Results
K63-ubiquitylation is required to maintain genome
integrity
To examine the involvement of K63 ubiquitylation in DSB
repair, we employed a strategy to selectively suppress K63-
ubiquitylation, using a mutant form of Ub in which lysine 63 is
replaced with arginine (K63RUb). Likewise, we overexpressed
WTUb in parallel to control for potential indirect effects K63RUb
overexpression might have in other ubiquitin mediated processes
(Fig. 1A). Expression levels of K63RUb mRNA were ,4 fold
lower than that of endogenous ubiquitin B expression (Fig. 1B), but
were sufficient to compete with WTUb and thus decrease K63-
ubiquitylation (Fig. 1C) without influencing total ubiquitylation,
which is mediated primarily via K48 linkage (Fig. S1A). FACS
analysis indicated that overexpression of K63RUb had no effect
on cell cycle distribution (Fig. 1D), in addition, proliferation of
WTUb- and K63RUb expressing cells is similar (Fig. S1B).
Strikingly, we observed that cells expressing K63RUb displayed a
dramatic increase in spontaneous mutations at the HPRT locus,
increasing approximately 200 fold from 1.2 mutations per 107
K63-Ubiquitylation Maintains Genomic Integrity
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WTUb expressing cells to 2.1 mutations per 105 K63RUb
expressing cells in 7 days of unperturbed growth (Fig. 1E; Fig.
S1C). This increase was not caused by differences in cell
proliferation (Fig. S1B). Treatment with IR or with agents that
promote replication-associated DSBs by inhibiting PARP (PARPi;
KU0058948) or topoisomerase I (camptothecin; CPT) resulted in
a further increase in mutations in K63RUb expressing cells
(Fig. 1F). These data indicate that K63RUb expressing cells
experience inaccurate repair of endogenous, IR, PARPi, and CPT
induced DNA damage.
K63-ubiquitylation has previously been implicated in the DNA
damage tolerance pathway, which is important for response to
ultraviolet (UV)-induced thymine dimers and other replication
blocking lesions [26,27]. In this pathway K63-ubiquitylation of
PCNA prevents point mutations introduced by error-prone
translesion polymerases [24,27,28,29]. In order to determine if a
similar mechanism was responsible for the increase in spontaneous
and DSB-induced mutations, we analysed individual HPRT
mutant clones. Of the spontaneous mutations 58% were single
nucleotide changes, which were all G:C to T:A transversions
(Fig. 1G; Table 1), consistent with endogenous 8-oxoguanine
mutagenesis induced by oxidative DNA damage [30,31]. In
addition, unlike what was observed following UV damage, 32% of
the spontaneous mutations were large scale deletions, and
moreover the increase in mutations induced by CPT and IR
was accounted for entirely by an increase in large-scale deletions
(Fig. 1G; Table 1). Furthermore, PCNA is not ubiquitylated in
response to DNA damage induced by CPT or IR [12,32,33]. To
further rule out that spontaneous and CPT-induced mutations in
the K63RUb cells are caused by impaired PCNA polyubiquityla-
tion we knocked down the E3 ligases HLTF and SHPRH (Fig.
S2A and B). Depletion of HLTF or SHPRH caused mutations
upon treatment with UV and MMS, respectively, as previously
shown [34]. Importantly depletion of HLTF or SHPRH did not
lead to spontaneous or CPT-induced mutations. Thus, PCNA
ubiquitylation is unlikely to be responsible for the genetic
instability observed in response to S-phase DSBs in the
K63RUb expressing cells.
We also assessed genomic instability by quantification of
endogenous and CPT-induced chromosome aberrations
(Fig. 1H). In untreated samples, K63RUb expressing cells had
nearly twice as many metaphases with aberrations (18%)
compared with WTUb expressing cells (10%). Following CPT
treatment, 44% of metaphases from K63RUb cells displayed
aberrations whereas this percentage (10%) was unchanged in
WTUb cells. The number of chromosomal aberrations increased
upon CPT treatment in both WTUb and K63RUb cells with 1.8-
and 3.7-fold, respectively (Fig. 1H right panel). These data suggest
that K63R cells experience more damage, have a DNA repair
defect and/or escape cell-cycle checkpoints to migrate to mitosis
with damage. Interestingly, asymmetrical radial chromosomes,
which are characteristic of HR defects in BRCA1-deficient cells
[35,36], were observed exclusively in the K63RUb expressing cells
(Fig. 1h). Since both spontaneous and CPT-induced collapsed
replication forks are repaired primarily through HR [16,37], these
data suggest a possible requirement for K63-ubiquitylation in this
pathway [16,37].
Disruption of K63-ubiquitylation sensitizes cells to
replication-associated DNA damage
To further investigate the repair defect in cells with suppressed
K63-ubiquitylation, we exposed cells to various doses of CPT,
PARPi, or IR and measured clonogenic survival. HR dependent
repair is known to be particularly important for sensitivity to CPT
and PARPi [21,37,38,39] whereas NHEJ plays a more important
role in the survival of cells to IR [40]. We found that cells
expressing K63RUb are markedly more sensitive to both CPT and
PARPi as compared to WTUb- or empty vector (EV) overex-
pressing cells, but show similar sensitivity to IR (Fig. 2A, B, C).
Similar results were obtained in immortalized MEFs expressing
WTUb or K63RUb (Fig. S3). Knockdown of HLTF or SHPRH
did not sensitize cells to CPT similarly to K63RUb expression (Fig.
S2C). These data indicate that cell survival after exposure to
agents that produce replication-associated DSBs is highly depen-
dent on functional K63 ubiquitylation.
The E2 enzyme UBC13 is known to catalyse specific formation
of K63-linked Ub chains in response to various types of DNA
damage [5,26,41,42]. To confirm our findings we depleted
UBC13 in A549 cells as an independent way to interfere with
K63-ubiquitylation. Partial UBC13 knockdown (Fig. S4A) was
sufficient to sensitize cells to both CPT and PARPi (Fig. S4B, C),
but not to IR (Fig. S4D). Together, these data indicate that
disruption of K63-ubiquitylation preferentially sensitizes cells to
agents that produce replication-associated DSBs. The lack of
sensitivity to IR in K63RUb cells (Fig. 2C) may be due to the fact
that the majority of DSBs are two-ended DSBs introduced directly
from radiation damage.
Disruption of K63-ubiquitylation results in S-phase
specific defects in DNA repair
To resolve the apparent discrepancy between IR-induced
mutation frequency and survival observed in K63RUb cells, we
assessed DNA repair kinetics at sites of damage by monitoring the
formation and resolution of DNA repair foci following treatment
with IR. K63-ubiquitylation has previously been shown to play an
important role in the recruitment and/or retention of BRCA1 and
53BP1 to direct DSBs [5,6,7,8,9,10,11]. Measuring the number of
cH2AX and 53BP1 foci per cell in response to IR revealed no
differences in the initial recruitment of cH2AX and 53BP1
(10 min post IR) to sites of damage between WTUb and K63RUb
expressing cells (Fig. 3A). However, we did observe an increase in
residual 53BP1 foci measured at 6 and 24 h following IR
treatment in K63RUb cells (Fig. 3A), a phenomenon that has
been associated previously with defects in repair that impact on
cell survival [43,44]. The reduced 53BP1 clearance observed in
K63RUb cells is also in line with slower resolution of cH2AX. It is
unclear whether these residual 53BP1 foci represent unresolved
direct DSBs or secondary replication-associated DSBs produced in
S-phase.
To investigate whether residual damage in K63RUb cells
originates from cells irradiated in S-phase, we pulse-labelled S-
phase cells with EdU immediately prior to IR treatment. Analysis
of residual foci in non S-phase (EdU negative) cells, or S-phase
(EdU positive) cells separately, revealed that the residual 53BP1
foci were almost exclusively present in the EdU positive fraction
(Fig. 3B; Fig. S5A). These results indicate that a repair defect of
IR-induced lesions is limited to S-phase in K63RUb cells. To
further address whether K63RUb cells are indeed compromised in
their ability to repair lesions produced during replication, we
treated cells with the S-phase specific DSB-inducing drug CPT for
2.5 hrs. As expected this treatment restricted damage to cells in S-
phase as shown by simultaneous staining with EdU and cH2AX
(Fig. 3C). Following a 1 h CPT treatment 53BP1 foci were
analyzed immediately (0 h) or 24 h after treatment (Fig. 3D).
Similar to the results with IR, a significant increase (p = 0.0309) in
residual 53BP1 foci was observed in K63RUb cells following CPT
treatment. In addition, we assessed DSB formation following
treatment with CPT and PARPi using cH2AX foci formation.
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Figure 1. K63RUb expression induces genomic instability. (A) Schematic overview of WTUb and K63RUb expression constructs. Expression of
a 6xHis-tagged WT or K63R ubiquitin B-GFP fusion protein is driven by the UBC promoter. (B) mRNA expression levels of endogenous ubiquitin B and
expressed 6xHis-tagged WT or K63R ubiquitin B determined by real-time PCR. (C) Impaired K63-linked ubiquitin chain formation, in untreated or CPT
(1h, 100nM) treated A549 K63RUb cells, confirmed by comparison to K63 ubiquitin chain abundance in A549 WTUb cells by Western blot using a K63-
chain specific antibody. Ponceau S staining indicates equal loading. (D) Cell cycle distribution of normal cycling A549 WTUb and K63RUb
overexpressing cells determined by FACS analysis. Data are mean of 3 independent exp’s 6 sd. (E-F) Mutations at the HPRT locus analysed in WTUb
and K63RUb HPRTmutant-free HAT-selected cells after (E) 0, 7 or 14 days proliferation (spontaneous), data are mean6 s.e.m. of 7 (7 days growth) and
2 (14 days growth) independent exp’s (n = 5-50 per exp). (F) 6 days continuous treatment with 1 mM PARPi, 5 or 20 nM CPT, 1 and 4 Gy IR, Ctrl is 7
days spontaneous. Data are mean 6 s.e.m. of 3 independent exps (n = 5 per exp). (G) A549 K63RUb cells were treated as described in (e) to obtain
spontaneous, CPT- and IR-induced HPRTmutated clones. RNA and genomic DNA were isolated from individual colonies and mutations were assessed
by sequence analysis of HPRT cDNA and/or exon1-9 presence was scored by exon-specific PCR amplification. (H) Metaphases of untreated or CPT-
treated (20 nM, 24 h) WTUb and K63RUb cells were harvested. Chromosomal aberrations were scored using giemsa-staining in 50 metaphases per
treatment. Data represents average 6 s.e.m. *P,0.05, **P,0.01, ***P,0.001.
doi:10.1371/journal.pone.0089997.g001
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Interestingly, the levels of cH2AX foci in the K63RUb expressing
cells were significantly increased compared to the WTUb cells
(Fig. 3E; Fig. S5B), demonstrating that K63RUb cells experience
more collapsed replication forks following treatment with CPT
and PARPi. Altogether these data indicate that disruption of K63-
ubiquitylation causes a specific defect in the repair of damage that
occurs during DNA replication.
Genetic instability following disruption of K63-
ubiquitylation is not due to NHEJ
In mammalian cells, DSBs are repaired by both error-free HR
and by error-prone non-homologous end-joining (NHEJ) path-
ways. HR and NHEJ can compete for repair of replication-
associated DSBs [40,45,46] and it has been suggested that NHEJ
factors may have a suppressive effect on HR [47]. To determine if
Table 1. Spontaneous, IR- and CPT-induced mutation spectra in K63R ubiquitin expressing cells.
Analysis Point Sequence Position Amino acid Mutant Analysis cDNA/ Deletion Deleted Mutant
cDNA mutation change gDNA positions
Spontaneous cDNA GAC -. TAC 579 Asp -. Tyr SP-C cDNA exon 8 deletion 699–776 SP-B
cDNA GAC -. TAC 579 Asp -. Tyr Sp-2 cDNA Part of exon 7 deletion 660–700 SP-6
cDNA TTG -. TTT 773 Leu -. Phe SP-4 cDNA exon 5 deletion 552–569 SP-13
cDNA GAC -. TAC 579 Asp -. Tyr SP-10 cDNA Part of exon 8 deletion 700–720 SP-15
cDNA G/C -. T/A GAC -. TAC 579 Asp -. Tyr SP-11 cDNA exon 5 deletion 552–569 SP-20
cDNA TTG -. TTT 773 Leu -. Phe SP-19 no cDNA -. gDNA exon 9 deletion SP-12
cDNA GGA -. TGA 801 Gly -. STOP SP-21 no cDNA -. gDNA no exon del. detected SP-A
cDNA GAC -. TAC 579 Asp -. Tyr SP-22 no cDNA -. gDNA no exon del. detected SP-3
cDNA GAC -. TAC 579 Asp -. Tyr SP-23
cDNA GAC -. TAC 579 Asp -. Tyr SP-24
cDNA CTT -. ATT 744 Leu -. Ile SP-17
IR cDNA TTT -. TAT 709 Phe -. Tyr IR #46 cDNA exon 6 deletion IR #42
cDNA GTG -. TTG 564 Val -. Leu IR #48 no cDNA -. gDNA exon 8,9 deletion IR #26
no cDNA -. gDNA exon 8,9 deletion IR #38
no cDNA -. gDNA exon 8,9 deletion IR #51
no cDNA -. gDNA exon 8,9 deletion IR #52
no cDNA -. gDNA exon 8,9 deletion IR #53
no cDNA -. gDNA exon 9 deletion IR #55
no cDNA -. gDNA exon 6,8,9 deletion IR #56
no cDNA -. gDNA no exon del. detected IR #36
no cDNA -. gDNA no exon del. detected IR #50
CPT cDNA GAC -. GAA 749 Asp -. Glu CPT #7 cDNA exon 4,5 deletion CPT #13
cDNA G/C -. T/A GGA -. TGA 801 Gly -. STOP CPT #15 no cDNA -. gDNA exon 4,6,8,9 deletion CPT #4
cDNA GGA -. TGA 801 Gly -. STOP CPT #21 no cDNA -. gDNA exon 9 deletion CPT #5
cDNA GGA -. TGA 801 Gly -. STOP CPT #26 no cDNA -. gDNA exon 3,4,5,6,8,9 deletion CPT #6
no cDNA -. gDNA exon 6 deletion CPT #8
no cDNA -. gDNA exon 8,9 deletion CPT #10
no cDNA -. gDNA exon 4,6,8,9 deletion CPT #11
no cDNA -. gDNA exon 4 deletion CPT #16
no cDNA -. gDNA exon 8,9 deletion CPT #23
no cDNA -. gDNA exon 4,6,8,9 deletion CPT #25
no cDNA -. gDNA exon 4,8,9 deletion CPT #29
no cDNA -. gDNA exon 4,6,8,9 deletion CPT #31
no cDNA -. gDNA no exon del. detected CPT #2
no cDNA -. gDNA no exon del. detected CPT #9
no cDNA -. gDNA no exon del. detected CPT #14
no cDNA -. gDNA no exon del. detected CPT #19
no cDNA -. gDNA no exon del. detected CPT #22
no cDNA -. gDNA no exon del. detected CPT #28
no cDNA -. gDNA no exon del. detected CPT #30
doi:10.1371/journal.pone.0089997.t001
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the increase in genetic instability and mutation rate observed
following suppression of K63-ubiquitylation was due to a switch
from HR to NHEJ we utilized a chemical inhibitor of DNA-
dependent protein kinase catalytic subunit (DNA-PKcs) (referred
to as DNA-PKi; KU0057788). Inhibition of DNA-PKcs alone had
no effect on cell survival in WT or K63RUb cells (Fig. 4A), and
similarly had no effect on the sensitivity to CPT (Fig. 4B). As
expected, inhibition of NHEJ sensitized cells to IR, but this was
equivalent in WT and K63RUb expressing cells (Fig. 4C).
Furthermore, inhibition of DNA-PKcs did not rescue the
increased spontaneous mutation frequency in K63RUb cells nor
that induced following CPT treatment (Fig. 4D). These data
indicate that K63RUb cells do not become more reliant on NHEJ
for repair of replication-associated DSBs and that the genetic
instability in these cells is not due to the classical NHEJ pathway.
K63-ubiquitylation dependent repair of replication-
associated DSBs is RNF8 independent
The E3 ligases RNF8 and RNF168 are known to mediate K63-
ubiquitylation of H2A and cH2AX at sites of IR-induced DSBs
[5,6,7,8,10,11]. To more directly investigate their role in the
response to replication-associated DSBs, we used siRNA against
both RNF8 and RAP80, a downstream ubiquitin binding protein
necessary for recruitment of BRCA1 to IR-induced DSBs.
Knockdown of RNF8 and RAP80 following double transfection
was at least 70% (Fig. 5A) and this was sufficient to sensitize
WTUb expressing cells to IR to an extent similar to that reported
previously, functionally validating the siRNA’s used (Fig. 5B)
[5,6,48,49]. However, depletion of RNF8 or RAP80 did not
sensitize cells to PARPi to a similar extent as that observed in cells
expressing K63RUb (Fig. 5C). Consistent with these data, knock-
down of RNF168 did not lead to reduced cell survival following
PARP inhibition (Fig. S6). Given our observation of the
importance of K63-ubiquitylation in controlling genetic stability
and mutation frequency, we also assessed spontaneous and IR-
induced mutations in cells following knockdown of RNF8 and
RAP80. Consistent with the sensitivity data, knockdown of RNF8
or RAP80 had no measurable effect on spontaneous or IR-
induced mutation frequency (Fig. 5D). These data suggest that the
requirement for K63-ubiquitylation in replication-associated
damage repair is independent of RNF8 or RAP80. We also
investigated a scenario in which the combination of partial defects
in PCNA polyubiquitylation and RNF8-dependent DSB signalling
would lead to the observed phenotype in K63RUb cells. We
generated cell lines with double knockdown of HLTF and RNF8
or SHPRH and RNF8 (Fig. 6A). Impairment of both signalling
pathways simultaneously did not cause spontaneous or CPT-
induced mutations nor did it lead to an increased sensitivity to
CPT-induced replication-associated DNA damage (Fig. 6B and
C). These data demonstrate that the observed K63R phenotype is
not due to combined effects of partial inhibition of these two DNA
repair pathways.
To further confirm the RNF8-independent function of K63-
ubiquitylation we performed the experiments in mouse embryonic
fibroblasts (MEFs) derived from the RNF8-/- mouse [25]. Stable
expression of the K63RUb transgene had no effect on cell
proliferation as compared to controls (Fig. S7A). As expected,
RNF8-/- cells demonstrated defective 53BP1 foci formation and
increased sensitivity to IR compared to WT MEFs (Fig. S7B, C)
[5,6,7]. Consistent with results in A549 cells, expression of
K63RUb in RNF8-/- cells did not increase the sensitivity to IR
(Fig. 7A) but did increase the sensitivity to both CPT and PARPi
treatment (Fig. 7B, C). These data confirm a unique and critical
role for K63-ubiquitylation in the response to replication-
associated damage inducing agents that is independent of RNF8.
Thus, although RNF8 is clearly important for K63-ubiquitylation
in response to IR-induced DSBs, it is unlikely to be the major E3
responsible for K63-ubiquitylation and protection against toxicity
and genetic instability in response to replication-associated DSBs.
Discussion
K63-ubiquitylation has previously been implicated in the
response to UV-induced damage, and in the response to direct
DSBs produced by IR. In this study, we identify a previously
unknown role for K63-ubiquitylation that contributes to the
maintenance of genome stability and cell survival and which is
specific for DNA replication-associated DSBs. This novel function
is supported by three key pieces of evidence. First, our data
demonstrate that suppression of K63-ubiquitylation through
expression of the K63RUb mutant results in a dramatic increase
in spontaneous mutations (.200 fold) at the HPRT locus (Fig. 1E;
Fig. S1C). A large proportion of these mutations (,30%) arise
from large-scale deletions or other complex rearrangements.
Whereas point mutations are thought to arise endogenously
through mis-incorporation of single nucleotides, these endoge-
nously produced large-scale deletions and rearrangements occur as
Figure 2. K63RUb expression sensitizes cells to replication-
associated DNA damage. (A-C) Clonogenic survival of A549 cells
expressing empty vector (EV), WTUb or K63RUb was determined after
(A) CPT (24h) treatment started following cell attachment. Data are
mean 6 sd. of 2 independent exp’s (n = 3 per exp). (B) Continuous
PARPi treatment, data are mean 6 sd. of 3 independent exp’s (n = 3 per
exp). (C) IR, data are mean 6 sd. of 3 independent exp’s (n = 3 per exp)
*P,0.05, **P,0.01, ***P,0.001.
doi:10.1371/journal.pone.0089997.g002
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a consequence of the misrepair of DSBs, including those at
collapsed replication forks [16,50]. The mutation rate in cells with
suppressed K63-ubiquitylation was further increased in response
to agents that induce DSBs. PARPi, CPT and IR increased the
mutation rate in these cells by an additional 1.7-, 4.3- and 5-fold,
respectively (Fig. 1F). Strikingly, this increase was due entirely to
an increase in large-scale deletions, which accounted for 50-65%
of the total mutations observed (Fig. 1G). Since DSBs produced by
CPT and PARPi occur exclusively in S-phase as a consequence of
replication fork collapse, these data imply that K63-ubiquitylation
Figure 3. K63RUb expression induces S-phase specific repair defects. (A) WT and K63R Ub cells were fixed and immuno-stained for cH2AX
and 53BP1 foci at the indicated time points following 2 Gy IR or untreated (Ctrl). Mean values6 sd. of 2 independent exp’s,.150 cells were analysed
per time-point (B) 30 min EdU (10 mM) incorporation before 2 Gy IR, cells were fixed 30 min or 24 hrs post IR, EdU and 53BP1 foci were visualized by
fluorescent staining and quantified. Mean values6 s.e.m. of 2 independent exp’s (n.100 per treatment). (C) 30 min EdU (10 mM) incorporation alone
(untreated) or before 2.5 h 100 nM CPT treatment. Cells were fixed and immuno-stained for EdU and cH2AX 3 h post treatment. (D) Quantification of
53BP1 foci. Cells were fixed and immuno-stained for 53BP1 directly or 24 h after 1 h 100 nM CPT treatment, .80 cells were analysed per sample. (E)
Quantification of cH2AX immuno-staining of untreated (Ctrl) or 1 h 100 nM CPT treated cells. Mean values 6 s.e.m. Data is representative exp
(n.130) of 3 independent exp’s, *P,0.05.
doi:10.1371/journal.pone.0089997.g003
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participates in their repair. The instability following suppression of
K63-ubiquitylation is not specific to the HPRT locus, as we also
observed an increase in both spontaneous and CPT-induced
chromosomal aberrations (Fig. 1H) at short times after treatment.
This increase is consistent with a defect in DSB repair, particularly
in HR – the dominant DSB repair pathway during DNA
replication, although we cannot exclude the involvement of other
DNA repair mechanisms [16,37,51,52,53].
Second, we find that suppression of K63-ubiquitylation
selectively increases the toxicity of replication-associated DNA
damage. Cells stably expressing the K63RUb mutant are sensitive
to CPT- and PARPi-induced death (Fig. 2A, B), agents that induce
their cytotoxic effects through production of collapsed replication
forks in S-phase [21,22,37]. In contrast, expression of K63RUb
did not increase the cellular sensitivity to IR (Fig. 2C), which
produces DSBs throughout all phases of the cell cycle and which
are repaired primarily through NHEJ [54]. This result was
somewhat unexpected given that RNF8 and RNF168 mediate
K63-ubiquitylation of histones at IR-induced DSBs and defects in
these genes cause mild sensitivity to IR [5,6,7,9,10]. However, it
has been reported that the predominant form mediated by RNF8
is di-ubiquitylated cH2AX [5,7]. It is important to note that stable
expression of K63RUb suppresses, but does not entirely eliminate
K63-ubiquitylation. The K63RUb mutant competes with endog-
enous Ub and its expression was ,4-fold lower than endogenous
ubiquitin B (Fig. 1B). This resulted in a substantial reduction, but
not elimination of K63-ubiquitylation (Fig. 1C). These cells may
therefore be considered ‘hypomorphic’ with respect to their ability
to create these K63-Ub chains. The observation that this level of
suppression selectively sensitizes cells to replication-associated
DSBs implies that K63-ubiquitylation plays a more critical role in
their repair as compared with IR-induced DSBs. We speculate this
may be due to differences in K63-ubiquitylation chain length, as
the effect of K63RUb expression will increase with chain length.
In this regard, it is interesting that in contrast to IR-induced DSBs,
RNF8 is unlikely to be the sole or primary mediator of K63-
ubiquitylation in response to replication-associated breaks. Addi-
tional suppression of K63-ubiquitylation in RNF8 knockout cells
further sensitized cells to replication-associated damage but not to
IR (Fig. 7A, B, C). Importantly, RNF8 knockdown did not
increase genomic instability at the HPRT locus (Fig. 5D). In
addition, the K63R phenotype of increased mutation and
sensitivity following replication-associated breaks was not due to
combined effects of inhibited PCNA polyubiquitylation and
defective RNF8-dependent DSB signalling (Fig. 6B and C). These
disparate phenotypes support a unique role for K63-ubiquitylation
in response to replication-associated DSBs and imply that a
separate, as yet undetermined E3 ligase, is responsible for their
formation in response to this type of damage.
Third, analysis of 53BP1 and cH2AX foci following treatment
with DSB-inducing agents reveals an S-phase specific DNA repair
defect in cells with impaired K63-ubiquitylation. In agreement
with the lack of sensitization observed following treatment with IR,
suppression of K63-ubiquitylation did not cause a general defect in
establishment or resolution of 53BP1 foci at the majority of IR-
induced DSBs. However, we did detect a delay in the resolution of
Figure 4. K63RUb phenotype is not due to NHEJ. (A-C) Clonogenic survival of WT and K63R Ub cells after treatment with (A) 1 mM DNA-PKi
alone for indicated times, (B) 1 mM DNA-PKi for 24 or 48 hrs, started 1 h before combined 24 hrs treatment with 50 nM CPT or (C) 1 mM DNA-PKi for
24 hrs, started 1 h before 2 Gy IR (A-C) mean 6 s.d. (n = 3). (D) Mutations at the HPRT locus were determined after continuous treatment with 1 mM
DNA-PKi started 1 h before combined with additional treatments either spontaneous or 20 nM CPT for 6 days total, mean 6 s.d. (n = 5).
doi:10.1371/journal.pone.0089997.g004
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some of these foci, as indicated by an increase in residual foci
remaining at 6 and 24 hours after IR (Fig. 3A, B). Importantly, the
increase in residual 53BP1 foci was observed primarily within cells
that were in S-phase at the time of irradiation (Fig. 3B). Similarly,
suppression of K63-ubiquitylation resulted in a significant increase
in 53BP1 residual foci following CPT-treatment, which produced
DSBs and 53BP1 foci exclusively in S-phase cells (Fig. 3C).
Elevated levels of residual repair foci have been observed
previously in cells with defects in DSB repair and their levels
correlate well with cell death [43,44,51]. Analysis of cH2AX foci
produced in response to CPT and PARPi treatment provides
additional support for a defect in repair or signalling during S-
phase in K63RUb expressing cells. The levels of cH2AX were
significantly higher than wild-type cells at the end of CPT
treatment, presumably reflecting an increase in the number of
replication forks that have collapsed to produce DSBs (Fig. 3E).
Together these data indicate that K63-ubiquitylation is important
for the signalling and repair of DSBs produced during DNA
replication. However, the large increase in mutation frequency
(,90 fold) in K63R cells following CPT treatment cannot be
accounted for by increased levels of damage alone (1.3 fold
increase in cH2AX foci). Thus, although there may be a small
increase in damage formation, the primary defect is one in repair,
and specifically repair fidelity, which leads to mutation.
The nature of the repair defect in S-phase responsible for the
observed genetic instability of K63RUb expressing cells is not yet
understood. Both of the primary DSB repair pathways, HR and
NHEJ, can attempt repair of replication-associated lesions
although HR is dominant [45,46,53]. Our data rules out one
obvious explanation, namely that the rise in mutations is due to
increased reliance of the classical, error-prone NHEJ pathway.
Inhibition of the NHEJ protein DNA-PKcs resulted in strong
sensitization to IR, but did not prevent mutation induction, and
was not synergistically toxic in cells deficient in K63-ubiquitylation
(Fig. 4A, B, C, D). However, our data do not rule out the
possibility that elements of the NHEJ pathway may be involved.
Recently, BRCA1 was reported to displace 53BP1 at sites of DSBs
to enable HR-dependent repair [36]. The importance of this
activity was demonstrated by the fact that chromosome instability
and sensitivity to CPT and PARPi in BRCA1 cells was rescued by
deletion of 53BP1 [36]. A model was proposed whereby 53BP1
prevented DSB end-resection necessary for HR, and instead
promoted formation of aberrant chromatid fusions by Lig4 of the
NHEJ pathway. Thus, 53BP1 seems to play an essential role in
repair pathway choice for S-phase specific chromatid breaks.
Intriguingly, suppression of K63-ubiquitylation results in a
phenotype comparable to BRCA1 deficiency and BRCA1 can
form a heterodimeric E3 ubiquitin ligase complex with BARD1
Figure 5. RNF8 depletion does not reproduce K63RUb phenotype. (A-C) WT and K63R Ub cells were transfected with siRNA against RNF8 or
RAP80 on day 1 and 3. (A) Knockdown of RNF8 and RAP80 was assessed by mRNA expression levels determined by real-time PCR. Clonogenic survival
was assessed after (B) 4 Gy IR and (C) PARPi (continuous) (B-C) Data are mean 6 s.d. of 2 independent exp’s (n = 3 per exp). (D) Spontaneous and IR-
induced (4 Gy) mutations were determined at the HPRT locus, mean6 s.e.m. of 3 independent exp’s (n = 10 per exp), *P,0.05, **P,0.01, ***P,0.001.
doi:10.1371/journal.pone.0089997.g005
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[55,56], which we found was also required for resistance to PARPi
(data not shown). It is thus tempting to speculate that BRCA1 may
be required for K63-ubiquitylation and removal of 53BP1 at sites
of collapsed replication forks. The increase in S-phase specific
residual 53BP1 foci in K63RUb expressing cells (Figure 3A, B, D)
supports this possibility.
These data extend the role that K63-ubiquitylation plays in
maintaining genomic stability in response to S-phase specific
damage, which occurs as part of at least two distinct repair
pathways. In the DNA damage tolerance (DDT) pathway, K63-
ubiquitylation of PCNA prevents introduction of single nucleotide
mutations by error-prone translesion polymerases [24,27]. Our
findings indicate that K63-ubiquitylation plays a role in main-
taining genetic stability in response to DSBs in S-phase that are
associated with replication fork collapse. Further elucidation of the
underlying mechanism for defective repair and identification of the
Figure 6. Dual inhibition of PCNA and RNF8 signalling pathways does not mimic the K63RUb phenotype. (A) Depletion of HLTF or
SHPRH in combination with knock-down of RNF8 was achieved using lentiviral shRNA’s and was confirmed using real-time PCR. (B) Spontaneous or
CPT (20 nM) induced mutations were determined at the HPRT locus, mean 6 s.d. (n = 5) per exp). (C) Clonogenic survival of A549 cells after double
knock-down of HLTF and RNF8 or SHPRH and RNF8 was determined after treatment with 100 nM CPT (24 h). Data are mean 6 s.d. (n = 3), *P,0.05,
**P,0.01, ***P,0.001.
doi:10.1371/journal.pone.0089997.g006
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ubiquitin ligases and substrates may provide potential targets to
increase the efficacy of S-phase specific chemotherapeutic agents.
Supporting Information
Figure S1 K63RUb expression does not affect overall
ubiquitylation. (A) Western blot analysis using an antibody
against ubiquitin. Ponceau S staining indicates equal loading. (B)
Cell proliferation curve of A549 WTUb and K63RUb expressing
cells. (C) Spontaneous mutation rate at the HPRT locus of WTUb
and K63RUb cells on log-scale to visualize the difference.
(TIF)
Figure S2 Depletion of E3 ligases HLTF and SHPRH
does not reproduce the K63RUb phenotype. (A) Knock-
down of HLTF or SHPRH using lentiviral shRNA was confirmed
by real-time PCR. (B) Spontaneous, CPT- (20 nM), UV- (20 J/
m2) or MMS- (2 mg/ml) induced mutations were determined at
the HPRT locus, mean 6 s.d. (n = 5). (C) Clonogenic survival of
A549 cells expressing an shRNA against HLTF, SHPRH or empty
vector (pLKO.1) was determined after treatment with 100 nM
CPT (24 h). Data are mean 6 s.d. (n = 3).
(TIF)
Figure S3 K63RUb expression sensitizes WT MEFs to
DNA damage in S-phase. (A-C) Clonogenic survival of WT
MEFs expressing WTUb or K63RUb was determined after (A)
CPT (24 h) treatment started following cell attachment, (B)
continuous PARPi treatment, (C) IR. (A-C) Data are mean 6
s.d. of 2 independent exp’s (n = 3 per exp).
(TIF)
Figure S4 Loss of UBC13 sensitizes to replication-
associated DSBs. (A) Knock-down of UBC13 using lentiviral
shRNA was confirmed by real-time PCR. (B-D) Clonogenic
survival of A549 cells expressing empty vector (pLKO.1) or
shRNA against UBC13 was determined after (B) CPT (24 h)
treatment started following cell attachment. Data are mean 6 sd.
of 2 independent exp’s (n = 3 per exp). (C) continuous PARPi
treatment, data are mean 6 sd. of 2 independent exp’s (n = 3 per
exp). (D) IR, data are mean6 sd. of 2 independent exp’s (n = 3 per
exp).
(TIF)
Figure S5 (A) Enlarged immunostaining images shown in Fig. 3b
of the manuscript (B) Quantification of cH2AX immuno-staining
in WTUb and K63RUb cells treated for 6 and 24 hrs with 1 mM
PARPi. Mean values 6 s.e.m. of representative exp (n.100 per
treatment).
(TIF)
Figure S6 K63R induced PARPi sensitivity is not
mediated by RNF168. (A) Knock-down of RNF168 using
siRNA was confirmed by WB. Actin was used as loading control.
(B) Clonogenic survival of A549 cells transfected with siRNF8,
siControl or untransfected was determined after continuous
PARPi treatment, data are mean 6 sd. of 2 independent exp’s
(n = 3 per exp).
(TIF)
Figure S7 Validation of WT MEFs and RNF8-/- MEFs.
(A) Proliferation curve of uninfected RNF8-/- MEFs and lentiviral
infected RNF8-/- MEFs expressing empty vector (EV) or
K63RUb. (B) Clonogenic survival of WT MEFs and RNF8-/-
MEFs following IR. Data are mean 6 sd. of 2 independent exp’s
(n = 3 per exp). (C) WT MEFs and RNF8-/- MEFs uninfected or
expressing EV or K63RUb cells were fixed and immuno-stained
for cH2AX and 53BP1 foci following 2 Gy 30 min. Infection of
RNF8-/- cells with the different constructs did not affect the defect
in 53BP1 foci formation.
(TIF)
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